Company Data
Spyre Therapeutics Inc.
Ticker
SYRE
Current Price
$15.28 -1.74%
Market Cap
$922.2M
Price Target
Refer to Report
Volume
380.8K
52wk Range
$10.91 - $40.26
Overview
Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company’s lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an early clinical development stage.